Navigation Links
Tufts University calls for moderate approach to teaching personalized genomic testing
Date:1/24/2011

BOSTON (January 24, 2011) Genetics in Medicine, the official journal of the American College of Medical Genetics, published this month a paper by Tufts University faculty calling for a moderate, strategic approach to teaching personalized genomic testing in medical school curricula.

For 16 months, a multi-disciplinary group of Tufts University faculty examined ways to improve education regarding personalized genomic testing at Tufts University School of Medicine (TUSM). The genesis of the debate centered on whether medical students should use their own genome for educational purposes.

"We started with the basic agreement that doctors of today and tomorrow need to learn how to use genomic information responsibly and safely, and that this material was lacking in the curriculum," said Diana W. Bianchi, MD, Professor of Pediatrics, Obstetrics and Gynecology at TUSM.

"We thought that introducing a personal genetics component into the medical school curriculum would offer an exceptional opportunity for students to learn first-hand about the process, and would enable them to be trained to evaluate the analytic and clinical validity, as well as the clinical utility, of the data," says David Walt, Robinson Professor of Chemistry at Tufts University School of Arts and Sciences. Walt, a co-founder of Illumina, suggested that the Tufts medical students' own personal genotypes could serve as a backdrop for teaching issues related to clinical implementation, including the potential benefits and harms of these tests.

The faculty group conducted extensive meetings with the school's deans of education and student services to determine how the information might adversely affect students. In particular, they were concerned about the impact on student mental health if an abnormality were discovered.

"We concluded that if an institution is going to offer personalized genetic testing to its trainees, a plan should be made regarding both protection of privacy and follow-up of abnormal tests. Students should be told in advance of testing where to go for counseling regarding abnormal results, and who will pay for such counseling," explained Bianchi.

The TUSM faculty group recommended that curriculum committees explore ways of enriching educational content in the curriculum with genetics, genomics, genome-wide association studies (GWAS) and sequencing using anonymous or publicly accessible genomes. Discussion of the benefits, limitations, and potential harms of such testing should be an integral part of the educational process.

"We strongly advocate that genomic analysis and personalized medicine is a necessity for modern medical school education, both to be able to translate the advances made in genetic analysis and knowledge into improvements in human health and to begin to think of diseases as disruptions in specific pathways. Our experiences illustrate that adding this material to a medical school curriculum is a complex process that deserves careful thought and broad discussion within the academic community," added Walt.


'/>"/>

Contact: Christine Fennelly
617-636-3707
Tufts University, Health Sciences
Source:Eurekalert

Related medicine news :

1. Tufts researcher elected 2010 AAAS Fellow for work in superbugs and heat-stable vaccines
2. Impressive lineup of speakers at Tufts nutrition conference
3. Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions
4. Speaking the same language means better health care quality, Wayne State University study finds
5. Wayne State University study predicts risk of memory loss in healthy, older adults
6. Case Western Reserve/University Hospitals join nationwide HIV vaccine clinical trial
7. University of Oklahoma scientists discover way to stop pancreatic cancer in early stages
8. Thomas Jefferson University professor elected AAAS Fellow
9. Case Western Reserve University School of Medicine launches the National Childrens Study
10. University of Houston receives $5 million grant from Houston Endowment
11. Boston University School of Medicine awarded grants to improve early detection of lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... Virginia (PRWEB) , ... September 20, 2017 , ... ... Flex Pure Clinical Plus Coating System for clients that rely on safety and ... the growth of microorganisms. , Silver has been used for centuries for its ...
(Date:9/20/2017)... ... September 20, 2017 , ... Mirror Mirror Beauty Boutique ... Look Awesome This Autumn with CoolSculpting®. Scheduled for Thursday, September 28th, the afternoon ... Mirror Mirror Beauty Boutique is Houston’s largest CoolSculpting provider, holding the ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic Trainers from ... Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, evidence based ... Trainers are acknowledged by their peers with accolades and highly prestigious awards. This ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t have the authority ... gouging for their prescription drugs, according to a new comparison of drug plans ... our behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story ... average life. This mouse sets out on a journey that will show that friends ... the creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... -- Eli Lilly and Company (NYSE: LLY ... more efficiently focus resources on developing new medicines ... reductions, including those from a U.S. voluntary early ... positions. With the streamlining efforts ... $500 million that will begin to be realized ...
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
Breaking Medicine Technology: